CD34 and head and neck squamous cell carcinoma: We observed a delayed onset of T-cell development starting at 15 weeks in this experiment using CD34+ cells from an adult HNSCC patient, whereas CB-derived CD34 cells support superior engraftment and T-cell development as early as 12 weeks after transplantation [14,15].